A
Ami M. Perri
Researcher at University of Toronto
Publications - 14
Citations - 258
Ami M. Perri is an academic researcher from University of Toronto. The author has contributed to research in topics: Glycogen & Gene. The author has an hindex of 7, co-authored 12 publications receiving 174 citations. Previous affiliations of Ami M. Perri include University of Western Ontario.
Papers
More filters
Journal ArticleDOI
Abnormal glycogen chain length pattern, not hyperphosphorylation, is critical in Lafora disease
Felix Nitschke,Mitchell A. Sullivan,Mitchell A. Sullivan,Peixiang Wang,Xiaochu Zhao,Erin E. Chown,Ami M. Perri,Lori Israelian,Lucía Juana-López,Paola Bovolenta,Santiago Rodríguez de Córdoba,Martin Steup,Berge A. Minassian,Berge A. Minassian +13 more
TL;DR: It is concluded that laforin's principle function is to control glycogen chain lengths, in a malin‐dependent fashion, and that loss of this control underlies LD.
Journal ArticleDOI
Prioritizing Variants in Complete Hereditary Breast and Ovarian Cancer Genes in Patients Lacking Known BRCA Mutations.
Natasha G. Caminsky,Eliseos J. Mucaki,Ami M. Perri,Ruipeng Lu,Joan H.M. Knoll,Peter K. Rogan +5 more
TL;DR: Information theory (IT) is applied to predict and prioritize noncoding variants of uncertain significance in regulatory, coding, and intronic regions based on changes in binding sites in these genes.
Journal ArticleDOI
Skeletal Muscle Glycogen Chain Length Correlates with Insolubility in Mouse Models of Polyglucosan-Associated Neurodegenerative Diseases.
Mitchell A. Sullivan,Mitchell A. Sullivan,Silvia Nitschke,Evan P. Skwara,Peixiang Wang,Xiaochu Zhao,Xiao S. Pan,Erin E. Chown,Travis Wang,Ami M. Perri,Jennifer P.Y. Lee,Francisco Vilaplana,Berge A. Minassian,Berge A. Minassian,Felix Nitschke +14 more
TL;DR: The separation of soluble and insoluble muscle glycogen is described, enabling separate analysis of each fraction and demonstrating that hyperphosphorylation is not a basic feature of insoluble glycogen.
Journal ArticleDOI
A unified analytic framework for prioritization of non-coding variants of uncertain significance in heritable breast and ovarian cancer
Eliseos J. Mucaki,Natasha G. Caminsky,Ami M. Perri,Ruipeng Lu,Alain Laederach,Matthew Halvorsen,Joan H.M. Knoll,Peter K. Rogan +7 more
TL;DR: A strategy for complete gene sequence analysis followed by a unified framework for interpreting non-coding variants that may affect gene expression is presented and large numbers of variants detected by NGS are distilled to a limited set of variants prioritized as potential deleterious changes.
Journal ArticleDOI
An inducible glycogen synthase-1 knockout halts but does not reverse Lafora disease progression in mice
Silvia Nitschke,Silvia Nitschke,Erin E. Chown,Xiaochu Zhao,Shoghig Gabrielian,Sara Petković,Dikran R Guisso,Ami M. Perri,Peixiang Wang,Saija Ahonen,Felix Nitschke,Berge A. Minassian,Berge A. Minassian +12 more
TL;DR: The study shows that Gys1 knockdown is a powerful means to prevent LD progression, but this approach did not reduce brain glycogen or LBs to levels below those at the time of intervention, which suggests that endogenous mechanisms to clear brain LBs are absent or, possibly, compromised in laforin-deficient murine LD.